Society for Maternal-Fetal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery

We appreciate the detailed, evidenced-based review of thromboprophylaxis for cesarean delivery in “The Society for Maternal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery.” In their recommendations, the authors state, “Compared with UFH [unfractionated heparin], enoxaparin has the advantage of better bioavailability, longer half-life, more predictable antico agulation effect, less bleeding risks, and less risk of heparin-induced thrombocytopenia and osteopenia. We recommend the use of LMWH [low molecular weight heparin] as the preferred thromboprophylactic agent in pregnancy and the postpartum period.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Letter to the Editors Source Type: research